We recently published a list of 20 AI News and Analyst Ratings You Should Not Miss. In this article, we are going to take a ...

After listening to the enterprise AI specialist's latest earnings call, I have some concerns over where the company is headed ...

C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

The new iteration of C3 Pharmaceuticals, Inc. announced that it executed a tailored Share Subscription Agreement (SSA) with ...

One of the biggest headwinds looming for C3.ai: whether Baker Hughes, its most important customer, extends its partnership in ...

C3.ai's growth is fairly modest given its size and the strength of the demand environment. Read why I remain neutral on AI ...

Investors should always rely on their own analysis, not just management talk and projections, when deciding whether to buy a stock.

Executives are fighting back against a federal court decision that banned them from the securities industry and ordered them ...

Let's review those challenges and see if it's the right time to buy or sell C3.ai's stock while it's still trading about 50% ...

Whether you immediately recognize the name Tom Siebel or not, you’re likely familiar with the companies he’s led—Oracle, ...

This was the stock's fourth consecutive day of gains.

Enterprises and institutions are rushing to develop an AI strategy, which will be a tailwind for these two AI stocks.